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Introduction
Two methods are commonly used for the determination of uric
acid--the first is according to Praetorius and Poulsen [1] and
the second was devised by Kageyama I-2]. Neither method is
readily applicable to he KONE CD analyser (manufactured by
KONE OY, Finland).
The new aldehyde dehydrogenase (ALDH) method, pro-
posed by Haeckel [3] and improved by Bartl et al. 1-4-],
overcomes many of the disadvantages in Praetorius’s and
Kageyama’s methods. This paper presents the results of tests on
two commerically available reagents for the ALDH method for
their applicability to the KONE CD. One of these reagents is
produced by Boehringer Mannheim and is formulated accord-
ing to Bartl. The other is manufactured by Human and is
formulated according to the original Haeckel prescription=
Bartl’s method avoids the disturbing effect of ethanol-
converting enzymes by the addition of oxalic acid and pyrazole,
and also has a large linear range due to the use of xanthine,
which is a competitive inhibitor of uricase. Moss [5] described
in detail the enzymatic determination of uric acid by the
equilibrium procedure, measurement of two-point kinetics, and
measurement of the initial rate of reaction. Moss showed that
two-point kinetic measurement is the best method available.
Due to the long lag time of the KONE CD’s initial reading,
a blank-corrected equilibrium method cannot be used. Normal
end-point determination appears to be slow and reagent
consuming. It was therefore decided to optimize the two-point
kinetic method for use on the KONE CD.
Materials
Reafents
Uric acid, ALDH method, No. 242616 supplied by Boehrinfer
Mannheim, FR Germany.
Each kit contains one bottle of buffer and ethanol (66 ml); three
bottles ofNADP, catalase, and ALDH (lyophilized); one bottle
ofuricase (300/A). When the lyophilisate is dissolved in 20 ml of
buffer, and 15 ml of demineralized water and 100/A of uricase
solution are added, the concentrations of the reactants are:
Pyrophosphate buffer: 45 mmol/1
Pyrazole: 70 mmol/1
Sodium oxalate: 70 mmol/1
Xanthine: 0"24 mmol/1
Ethanol: 1.71 mol/l
NADP: 0.57 mmol/l
Catalase: 570 kU/1
ALDH: 570 U/I
Uricase: 186 U/1
Fully enzymatic uric acid, No. H1004 manufactured by Human of
Taunusstein, FR Germany.
Each Human kit contains two bottles of buffer and ethanol
(50ml each); three bottles of NAD, catalase, and ALDH
(lyophilized); and one bottle of uricase (600 /A). When the
lyophilisate is dissolved in 25 ml of buffer, and 200 #1 of uricase
solution is added, the concentrations of the reactants are:
Pyrophosphate buffer: 42 mmol/1
Ethanol: 1"43 mol/1
NAD + 0"706 mmol/l
Catalase: 933 kU/1
ALDH: 333 U/1
Uricase: 30 U/1
The xanthine was supplied by Fluka A.G. ofBuchs, Switzerland,
and xanthine oxidase by the Calbiochem-Behring Corporation
of La Jolla, USA.
Specimen
The calibration serum used was Calibrated Automated Lock-in,
lot No. 1217049, lyophilized human serum from General
Diagnostics of the USA. The control sera were Autonorm
bovine lot No. 218 supplied by Nyegaard, bovine serum lot
No. 0864058 from General Diagnostics, and bovine serum lot
No. K 5444-1 from Wellcome Reagents Ltd. The Human
controls used were Ortho normal control serum-unassayed lot
No. 11T222 and Ortho abnormal control serum-unassayed lot
No. 12T322 from Ortho Diagnostics, Belgium. Sera from
patients at the Academic Hospital were used in the correlation
studies. The specimens were collected in evacuated blood-
collection tubes, and were centrifuged within 15 min. ofclotting.
Serum was assayed on the reference instrument; the interval of
testing between instruments was less than 3 h.
Apparatus
The two instruments used were the KONE CD (also known as
OLLI CD) which is made by KONE OY, SF-0232 Espoo,
Finland; and an SMA 6/60 Autoanalyzer, manufactured by the
Technicon Instruments Corporation, Tarrytown, NY 10591,
USA.
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Experiments and results
KONE CD procedures
All experiments were carried out at 30C. The samples were
added to the cuvettes with physiologic saline to a volume of
250/d, and then 300/tl of reagent solution was added. The
minimum final volume required for the absorbance readings
withKONE cuvette block No. 384 is 500 #1. Each cuvette block
contains 24 cuvettes. The wavelength ofmeasurement is 340 nm.
Boehringer Mannheim kit
To test whether the reaction follows pseudo-first-order kinetics,
-In(An-At) is plotted against time (see figure where
An=absorbance after completion of the reaction, and At= the
absorbance at time after starting the reaction). The reagent
solution was prepared by dissolving a bottle of lyophilisate in
20ml ofbuffer and adding 100 ul ofuricase (see curve in figure
1). To test whether this solution can be diluted further, a 20ml
aliquot was diluted with 14 ml of demineralized water (dilution
factor 1.7; see curve II in figure 1) and another 20ml aliquot was
diluted with 28 ml ofdemineralized water (dilution factor 2.4; see
curve II! in figure 1). Under all three reaction conditions, the
concentration of uric acid in the cuvette is 60 #mol/1.
As figure illustrates, the reaction does follow pseudo-first-
order kinetics over the measurement interval both for diluted
and undiluted reagents. Table presents the regression
equations from the pseudo-first-order kinetics at various uric
acid concentrations (40-120 #mol/1) with a reagent dilution
factor of 1.7. All the regression equations obtained for the
different uric acid concentrations are linear. The variation in
slope (rate constant) is significant. This variation is similar to the
slope obtained with undiluted reagent and with reagent diluted
2.4 times with demineralized water. However, despite this
variation in slope at reagent dilution factor 1.7, a good linear
uric acid dilution curve is obtained.
Table 1. Comparison of pseudo-first-order kinetics at
five uric acid concentrations [x time (in s) andy 1n(An
-A,)]. The reagent was diluted 1.7 times with demineral-
ized water.
Concentration of
uric acid in the
cuvette (/mol) y ax+ b Sa Sb Syx
40 y=0"02114 x+ 1"573 0"00028 0"027 0"018
60 y=0.01994 x+ 1’217 0"00018 0"019 0"015
80 y 0’01706 x+ 1"016 0"00007 0’007 0"008
100 y=0"01520 x+0"855 0"00007 0"007 0"009
120 y-0.01422 x+0"716 0"00006 0"006 0’008
Linearity
The linear relationship between the uric acid concentration and
A A34on is shown in figures 2 and 3. The variables are the
uricase concentration (figure 2), the time of measurement, and
the dilution of the reagent with demineralized water (figure 3).
With regard to the uricase concentration in the cuvette, 50.5 U/1
of uricase gives linearity up to 60 mol/1 uric acid in the cuvette
and at 101 U/1 uricase, the linear range extends at least to
120/mol/1. Since the linear range obtained with 101 U/1 uricase
is quite sufficient, the linearity at higher concentrations of
uricase was not investigated.
Dilution of the reagent with demineralized water and the
time of the first measurement affect the linearity as shown in
figure 3. When the first measurement is taken soon (i.e. 30 s) after
starting the reaction, the linearity is dependent on the extent of
the dilution. Of the first measurement is taken 50 after starting
the reaction, the three concentrations give similar curves, i.e.
small variations in the concentration of reagent in the cuvette
have no influence on the AA measured. Moreover, when the first
measurement is taken at 50 the reaction proves to be linear up
to an initial uric acid concentration in the cuvette of 120/mol/1.
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Figure 1. The effect ofdiluting the reagent on the reaction with uric acid. Where A absorbance at time t; A,, absorbance
after completion ofthe reaction. The wavelength ofmeasurement was 340 nm. Initial concentration ofuric acid in the cuvette
was 60 lamol/1. Curve I describes the undiluted reagent; curve II the reagent diluted 1.7 times with demineralized water; and
curve III is the reagent diluted 2"4 times with demineralized water.
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Figure 2. The effect of uricase concentration on the
linearity of the uric acid determination. The reagent was
diluted 1.7 times, The concentration ofuricase in the cuvette
was 50.5 U/l in graph (a) and 101 U/1 in graph (b).
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Figure 3. Effect diluting the reagent and the timing ofthe
absorbance readings on the linearity of the uric acid
determination. For graph I A A=(At_lsos-At=3os), and
for graph 11 AA =(At= 17os At= 5os); graph (a) is undiluted
reagent, graph (b) shows the reagent diluted 1.7 times with
demineralized water; and graph (c) is the reagent diluted 2"4
times with demineralized water.
This sensitivity, however, decreases if the first measurement is
taken at 50s.
TheKONE CD is connected electronically to the KONE C.
As a result, it is possible to determine accurately the time lag
between the addition of the reagent and the measurement. The
instrument has a minimum lag time between the addition of
reagent to three rows ofcuvettes in the cuvette block and the first
measurement. The shortest possible lag time varies between the
several program versions on the tape which is used to program
the KONE C. The best lag time is produced by KONE C’s
program version 3.2, which has a minimum lag time of40 at a
measuring time of 2 min. The newest program, program 4.0, has
a lag time of 50 s at a measuring time of 2 min.
In view of practical constraints, experiments with the
Boehringer Mannheim kit will, in future, be run using a lag time
of 50s.
Interferences
Interferencefrom xanthine oxidase
The Boehringer Mannheim kit contains xanthine in order to
increase the Michaelis constant; a test was made to discover
whether xanthine oxidase interferes in the determination of uric
acid. Shamma’a et al. [6] investigated the level of the enzyme
activity of xanthine oxidase in serum from patients with liver
diseases. They found marked increases in xanthine oxidase in the
serum from patients with infectious hepatitis. The values given
by Shamma’a et al. ranged from 1.9 to 1412 International mU/1
throughout the course of the disease. Only slight increases of
serum xanthine oxidase were found in patients suffering from
other diseases of the liver. Several concentrations of xanthine
oxidase were investigated. When 1500 ImU/1 was added to sera,
using routine assay conditions, an apparent increase in uric acid
(about 18/mol/l) was found. Thus only slight increases in uric
acid can be expected at high serum xanthine oxidase levels.
Interference from xanthine
Stepatschuk [7] found, at pathologic serum xanthine concen-
trations, an apparent decrease in urate with a uricase-based
method (Uricaquant, cat. No. 124753, supplied by Boehringer
Mannheim). His method uses low uricase concentrations during
kinetic measurement.
Since Hande et al. [8] noted serum xanthine concentrations
as high as 148 mg/l after a patient with Burkitt’s lymphoma was
treated with allopurinol, sera containing added xanthine up to
mmol/1 were analysed. At mmol/1 of xanthine and at a uric
acid concentration of 200/mol/1 an increase of 25/mol/1 was
found, at at a uric acid concentration of600 #mol/1 an increase of
40/mol/1 in uric acid was found.
Human kit
The Human kit was also tested to see if the reaction follows
pseudo-first-order kinetics. The experiments were carried out
with the following refigents: buffer volumes of 12, 15, 18, 25, 52
and 79 ml; uricase concentrations in the cuvette of 5, 10, 20 and
40 U/l; and uric acid concentrations in the cuvette of 12, 20, 30,
40, 50 and 60/mol.
Pseudo-first-order kinetics was not obtained under any of
these conditions.
Linearity
To find out whether the uric acid dilution curve is linear, dilution
curves were set up for all ofthe above reaction conditions. Non-
linearity was found at low uric acid concentrations. At higher
uric acid concentrations the curve is linear in relation to the
dilution. Non-linearity is more extreme the later the first
37G. A. Harff and F. Lamie Two-point kinetic determination of uric acid with the KONE CD analyser
measurement is taken from starting the reaction. At the shortest
possible lag time for 24 cuvettes (40 usingKONE C’s program
3.2) all the curves displayed poor linearity. When an LKB 8600
reaction-rate analyser was used a linear dilution curve was
obtained (lag time was 10s), although the reaction still did not
follow pseudo-first-order kinetics. A drawback of the KONE
CD is that it does not allow a short lag time.
Routine uric acid determination
For routine determination of uric acid with the KONE CD, it
was decided to use the Boehringer Mannheim ALDH method.
The KONE dispenser is programmed for 30C, for a 50 /1
sample and for 200 y1 of physiologic saline. It is unnecessary to
incubate the thermostatted cuvette, so 300 y1 ofstarter reagent is
added straight away. This starter reagent is prepared by adding
20 ml of buffer, 15 ml of demineralized water, and 100/A of
uricase to a bottle oflyophilized reagent. Since the linear range
extends to a concentration of 120/mol/1 in the cuvette (see
figure 3), the linear range for the serum is 1350 /mol/1. For
serum determination, this linearity is sufficient. The KONE
colorimeter was programmed with KONE program version 4.1
(figure 4). Controls used are Ortho normal and Ortho abnormal;
TF’=.k i
15 3RD STD CO!iC,
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Figure 4. KONE C program version 4.0.
these are both human sera and are part of the Ortho Quality
Program supplied by Ortho Diagnostics. Two S.D. limits were
applied to these sera for quality control of the results obtained
with serum samples from patients.
Day-to-day precision
To test day-to-day precision, 30 separate days’ lyophilized
bovine control sera were reconstructed with low, medium and
high concentrations. These three controls were analysed as
unknowns between the patients’ sera. The precision for
Autonorm was 4.3% (mean concentration 170#tool/l), for
General Diagnostics serum it was 3"5% (mean concentration
452 #tool/l) and for Wellcome serum 2.5% (mean concentration
737 ymol/1).
Correlation
Since the machine used for routine uric acid determination at the
Academic Hospital was changed from a Technicon SMA 6/60 to
a KONE CD system a correlation study was made between the
two instruments. The phosphotungstate reduction method was
used for the SMA 6/60. 100 patients’ samples were used in the
correlation experiment. The regression equation was calculated
using Deming’s method, which is recommended by Cornbleet
and Gochman [9]. Taking x for the SMA 6/60 and y for the
KONE CD, the regression equation was y= 1.042 x-43.1.
Syx 15" 8 (see figure 5).
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Figure 5. Correlation ofuric acid results; KONE CD with
Boehringer Mannheim ALDH reagent versus SMA 6/60
with the phosphotungstate reduction method.
Conclusions
The Human H1004 kit cannot be adapted for two-point kinetic
determination of uric acid on the KONE CD.
The procedure used with the Boehringer Mannheim kit No.
242616 is quick (allowing 300 determinations/h) and provides
good reproducibility of routine use.
In comparison with the phosphotoungstate reduction
method, the procedure followed with the Boehringer Mannheim
kit gives excellent linearity. Finally, only a minor interference is
to be expected in patients’ sera from xanthine oxidase and from
xanthine.
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Conference announcement
International Congress on Automation in the
Clinical Laboratory
IUPAC and the Sociedad Espafiola de Quimica
Clinica arejoint sponsors ofthis meeting, which will be
held in Barcelona, Spain, from 19 to 22 April 1981. The
Scientific Committee is chaired by Dr F. L. Mitchell:
the provisional scientific programme includes the
following:
19 April
Opening lecture: The technological revolution in the
clinical laboratory, by J. Buttner (FR Germany).
20 April
Plenary lecture: Automation in clinical chemistry,
current successes and trends for the future, by P. A.
Bonini (Italy).
Symposium: Solid phase chemistry, chaired by T. D.
Geary (South Africa).
Symposium: Systems for kinetic measurements,
chaired by H. L. Purdue (USA).
Symposium" Use of immobilized enzymes, chaired by
Ch. Collombel (France).
21 April
Plenary lecture" Automation in clinical microbiology,
H. Friedman (USA).
Symposium" Instruments for developing countries and
for operation in difficult circumstances, chaired by
F. L. Mitchell (UK).
Nomenclature for automated analysis (1), by M.
Hjelm (UK).
22 April
Plenary lecture: Automation in haematology" present
and future trends, by S. M. Lewis (UK).
Symposium" Cost analysis, chaired by R. Haeckel (FR
Germany).
Nomenclature for automated analysis (2), by M. Hjelm
(UK).
Symposium: Computer interfaces and patient identi-
fication, chaired by H. Keller (USA).
Symposium" New technology allowing pathology
near the patient (clinical chemistry, haematology and
microbiology), chaired by A. H. Free (USA).
The congress languages are English, Spanish and
French and simultaneous translation will be available
during the plenary sessions and symposia. Partici-
pants will be able to attend poster sessions, workshops
and a commercial exhibition during the three days of
the congress.
Papers presented at the congress will be published
in Pure and Applied Chemistry, abstracts of free
communications in this Journal.
The registration fee for people over 28 is now 12 000
pesetas, under 28s can register for 6000 pesetas. This
does not include travel, hotels or any meals.
Further details from the Secretariat, International
Congress on Automation in the Clinical Laboratory,
Apartado de Correos 543, Barcelona, Spain.
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